Edgewise Therapeutics (EWTX) announced the appointment of Michael Nofi, as CFO, effective November 10. Nofi joins Edgewise after serving as Chief Accounting Officer at SpringWorks Therapeutics. Nofi will succeed Edgewise CFO, Michael Carruthers, who is retiring.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EWTX:
- Edgewise Therapeutics Reports Q3 2025 Financial Results
- Edgewise Therapeutics reports Q3 EPS (39c), consensus (40c)
- Edgewise Therapeutics price target raised to $33 from $30 at JPMorgan
- Edgewise Therapeutics Advances with Phase 1 Study of EDG-15400
- Medpace and Edgewise Therapeutics Advance Becker Muscular Dystrophy Study